Nurix

SRA DNA Encoded Library Technology - (Brisbane, CA)

Nurix • $101K — $146K *
Pharmaceuticals & Biotech
Less than 5 years of experience
Job Overview by Ladders

Qualifications

  • B.S. or higher in Chemistry, Biochemistry, or Medicinal Chemistry with 2-5 years of relevant experience.
  • Strong foundation in synthetic organic chemistry required.
  • Hands-on lab experience specifically in synthesizing DNA-encoded libraries.
  • Familiarity with DNA-Encoded Library Technology workflows essential.
  • Experience with analytical tools like LCMS/HPLC for DNA-conjugate analysis.

Responsibilities

  • Design and validate novel DNA-encoded library builds.
  • Develop new DNA-compatible chemical transformations for DELs.
  • Construct DEL libraries supporting in-house production efforts.
  • Collaborate with external partners for DEL synthesis and follow-up strategies.
  • Participate in discussions to aid DEL screening, data analysis, and hit optimization.
  • Contribute to automation and technology development in the platform.
  • Present findings and document processes within the Discovery Chemistry team.

Benefits

  • Collaborative and team-oriented work environment.
  • Opportunities for hands-on learning and knowledge sharing.
  • Exposure to a fast-paced interdisciplinary research setting.
  • Commitment to scientific excellence and collaborative goals.
Full Job Description
Research Associate III/Scientist I, DNA Encoded Library Technology - Nurix Brisbane

Position

We are seeking a talented and motivated chemist to join our Discovery Chemistry team and contribute to the design and synthesis of DNA-encoded libraries (DELs). This hands-on position offers the opportunity to shape Nurix's DEL-based lead discovery platform, working at the interface of chemistry, biology, and automation. Key responsibilities:
• Design and validate novel DEL library builds.

Develop and bring in new DNA-compatible chemical transformations that can widen the DEL chemical space.
• Construct DEL libraries to support the in-house library production efforts.
• Work with external partners to support our DEL synthesis and hit follow up strategies.
• Engage in cross-functional team discussions that support DEL screening, data analysis, machine learning and hit-optimization.
• Contribute to platform automation and technology development efforts.
• Present results, document workflows, and contribute to scientific and strategic planning within the Discovery Chemistry organization.

Education and Experience
• B.S. or higher in Chemistry, Biochemistry, or Medicinal Chemistry. 2-5 years of industrial experience (title determined by experience).
• Strong background in synthetic organic chemistry.
• Hands-on laboratory experience synthesizing DNA encoded libraries.
• Familiar with the overall DNA-Encoded Library Technology workflow operations.
• Experience analyzing and purifying DNA-conjugates using common analytical tools (LCMS/HPLC).

Added Qualifications
• Experience working in the drug discovery field - drug design, synthesis, and SAR based hit-to-lead optimization.
• Experience working with high-throughput analytical and purification systems relevant to DEL-applications.
• Experience working with molecular biology tools (PCR, qPCR, Western Blot)

Fit with Nurix Culture and Values
• Collaborative and team-oriented, eager to share expertise and learn from others.
• Solution-driven with a hands-on and resourceful approach.
• Adaptable and comfortable in a fast-paced, interdisciplinary environment.
• Committed to scientific excellence and the shared goals of the team.

Location: Brisbane, CA

Salary Range:

RA III: $101,690 - 116,226
SRA: $118,893 - 139,310
Scientist I: $129,382 -146,679

Application Process

Applicants should be legally entitled to work for any employer in the US.

Note to Employment Agencies: Please do not forward any agency resumes. Nurix will not be responsible for fees related to unsolicited resumes.

About Nurix

Nurix Therapeutics is a biotechnology company that is focused on the discovery, development, and commercialization of small molecule therapies that modulate the ubiquitin proteasome system (UPS) for the treatment of cancer and other diseases. The company's proprietary drug discovery platform is based on the use of DNA-encoded libraries (DELs) to identify small molecules that selectively bind to E3 ligases, which are key enzymes in the UPS. Nurix's lead drug candidate, NX-2127, is a first-in-class small molecule inhibitor of the CBL-B E3 ligase that is being developed for the treatment of solid tumors and hematological malignancies. The company was founded in 2013 and is headquartered in San Francisco, California.
Learn more about Nurix
Size
135 employees
Market Cap
$486 million
Industry
Net Income
-$43.2 million
Founded
2009
Revenue
$17.8 million
NASDAQ

Similar Jobs

More Jobs at Nurix

More Pharmaceuticals & Biotech Jobs

Find similar SRA DNA Encoded Library Technology - (Brisbane, CA) jobs: